TFCP2 and hepatocellular carcinoma: Given the current large unmet medical need, further investigation into the relevance of the LSF–α-tubulin–SET8 pathway for hepatocellular carcinoma and other cancer types in which LSF is oncogenic may aid novel targeted and effective treatments.